189 related articles for article (PubMed ID: 37973913)
1. SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.
Liao SY; Rudoy D; Frank SB; Phan LT; Klezovitch O; Kwan J; Coleman I; Haffner MC; Li D; Nelson PS; Emili A; Vasioukhin V
Nat Commun; 2023 Nov; 14(1):7435. PubMed ID: 37973913
[TBL] [Abstract][Full Text] [Related]
2. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
[TBL] [Abstract][Full Text] [Related]
3. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
[TBL] [Abstract][Full Text] [Related]
5. EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
Zoma M; Curti L; Shinde D; Albino D; Mitra A; Sgrignani J; Mapelli SN; Sandrini G; Civenni G; Merulla J; Chiorino G; Kunderfranco P; Cacciatore A; Kokanovic A; Rinaldi A; Cavalli A; Catapano CV; Carbone GM
Nat Commun; 2021 Jul; 12(1):4147. PubMed ID: 34230470
[TBL] [Abstract][Full Text] [Related]
6. Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells.
Strittmatter BG; Jerde TJ; Hollenhorst PC
PLoS Genet; 2021 Jul; 17(7):e1009708. PubMed ID: 34314419
[TBL] [Abstract][Full Text] [Related]
7. Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells
Li P; He Y; Chen T; Choy KY; Chow TS; Wong ILK; Yang X; Sun W; Su X; Chan TH; Chow LMC
Mol Cancer Ther; 2021 Jan; 20(1):76-84. PubMed ID: 33268570
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation.
Kedage V; Strittmatter BG; Dausinas PB; Hollenhorst PC
J Biol Chem; 2017 Oct; 292(42):17225-17235. PubMed ID: 28887309
[TBL] [Abstract][Full Text] [Related]
9. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
[TBL] [Abstract][Full Text] [Related]
10. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
[TBL] [Abstract][Full Text] [Related]
11. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
Chen Y; Chi P; Rockowitz S; Iaquinta PJ; Shamu T; Shukla S; Gao D; Sirota I; Carver BS; Wongvipat J; Scher HI; Zheng D; Sawyers CL
Nat Med; 2013 Aug; 19(8):1023-9. PubMed ID: 23817021
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
Mao N; Gao D; Hu W; Gadal S; Hieronymus H; Wang S; Lee YS; Sullivan P; Zhang Z; Choi D; Rosen N; Sawyers CL; Gopalan A; Chen Y; Carver BS
Cancer Res; 2020 Apr; 80(7):1428-1437. PubMed ID: 32015092
[TBL] [Abstract][Full Text] [Related]
13. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
Kim TD; Shin S; Janknecht R
Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
[TBL] [Abstract][Full Text] [Related]
15. Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.
Raina K; Kant R; Prasad RR; Kandhari K; Tomar M; Mishra N; Kumar R; Fox JT; Sei S; Shoemaker RH; Chen Y; Maroni P; Agarwal C; Agarwal R
Mol Carcinog; 2022 Jul; 61(7):717-734. PubMed ID: 35452553
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.
Cappellari M; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Saarikettu J; Silvennoinen O; Sette C
Oncogene; 2014 Jul; 33(29):3794-802. PubMed ID: 23995791
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
Shen M; Wei Y; Kim H; Wan L; Jiang YZ; Hang X; Raba M; Remiszewski S; Rowicki M; Wu CG; Wu S; Zhang L; Lu X; Yuan M; Smith HA; Zheng A; Bertino J; Jin JF; Xing Y; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):43-59. PubMed ID: 35121987
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression.
Goel S; Bhatia V; Kundu S; Biswas T; Carskadon S; Gupta N; Asim M; Morrissey C; Palanisamy N; Ateeq B
Nat Commun; 2021 Sep; 12(1):5325. PubMed ID: 34493733
[TBL] [Abstract][Full Text] [Related]
19. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.
Zong Y; Xin L; Goldstein AS; Lawson DA; Teitell MA; Witte ON
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12465-70. PubMed ID: 19592505
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
